FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018317503> ?p ?o ?g. }

• W2018317503 abstract "Bradykinin type 2 receptor (B2BRK) genotype was reported to be associated with changes in the left-ventricular mass as a response to aerobic training, as well as in the regulation of the skeletal muscle performance in both athletes and non-athletes. However, there are no reports on the effect of B2BRK 9-bp polymorphism on the response of the skeletal muscle to strength training, and our aim was to determine the relationship between the B2BRK SNP and triceps brachii functional and morphological adaptation to programmed physical activity in young adults. In this 6-week pretest-posttest exercise intervention study, twenty nine healthy young men (21.5 ± 2.7 y, BMI 24.2 ± 3.5 kg/m2) were put on a 6-week exercise protocol using an isoacceleration dynamometer (5 times a week, 5 daily sets with 10 maximal elbow extensions, 1 minute rest between sets). Triceps brachii muscle volumes were assessed by using magnetic resonance imaging before and after the strength training. Bradykinin type 2 receptor 9 base pair polymorphism was determined for all participants. Following the elbow extensors training, an average increase in the volume of both triceps brachii was 5.4 ± 3.4% (from 929.5 ± 146.8 cm3 pre-training to 977.6 ± 140.9 cm3 after training, p<0.001). Triceps brachii volume increase was significantly larger in individuals homozygous for −9 allele compared to individuals with one or two +9 alleles (−9/-9, 8.5 ± 3.8%; vs. -9/+9 and +9/+9 combined, 4.7 ± 4.5%, p < 0.05). Mean increases in endurance strength in response to training were 48.4 ± 20.2%, but the increases were not dependent on B2BRK genotype (−9/-9, 50.2 ± 19.2%; vs. -9/+9 and +9/+9 combined, 46.8 ± 20.7%, p > 0.05). We found that muscle morphological response to targeted training – hypertrophy – is related to polymorphisms of B2BRK. However, no significant influence of different B2BRK genotypes on functional muscle properties after strength training in young healthy non athletes was found. This finding could be relevant, not only in predicting individual muscle adaptation capacity to training or sarcopenia related to aging and inactivity, but also in determining new therapeutic strategies targeting genetic control of muscle function, especially for neuromuscular disorders that are characterized by progressive adverse changes in muscle quality, mass, strength and force production (e.g., muscular dystrophy, multiple sclerosis, Parkinson’s disease)." @default.
• W2018317503 created "2016-06-24" @default.
• W2018317503 creator A5016158898 @default.
• W2018317503 creator A5041369083 @default.
• W2018317503 creator A5058418181 @default.
• W2018317503 creator A5079324651 @default.
• W2018317503 creator A5079822536 @default.
• W2018317503 date "2012-11-06" @default.
• W2018317503 modified "2023-09-25" @default.
• W2018317503 title "Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men" @default.
• W2018317503 cites W143880323 @default.
• W2018317503 cites W1544778514 @default.
• W2018317503 cites W1649582880 @default.
• W2018317503 cites W1853905915 @default.
• W2018317503 cites W1965381268 @default.
• W2018317503 cites W1967889368 @default.
• W2018317503 cites W1974044416 @default.
• W2018317503 cites W1993821350 @default.
• W2018317503 cites W2000494300 @default.
• W2018317503 cites W2004502880 @default.
• W2018317503 cites W2008459790 @default.
• W2018317503 cites W2017997943 @default.
• W2018317503 cites W2018151174 @default.
• W2018317503 cites W2040437662 @default.
• W2018317503 cites W2040632883 @default.
• W2018317503 cites W2056426365 @default.
• W2018317503 cites W2070235240 @default.
• W2018317503 cites W2072399660 @default.
• W2018317503 cites W2078819632 @default.
• W2018317503 cites W2079538435 @default.
• W2018317503 cites W2101547095 @default.
• W2018317503 cites W2120948451 @default.
• W2018317503 cites W2151440851 @default.
• W2018317503 cites W2153595787 @default.
• W2018317503 cites W2154851491 @default.
• W2018317503 cites W2160984983 @default.
• W2018317503 cites W2319237482 @default.
• W2018317503 cites W4245025766 @default.
• W2018317503 cites W1563811750 @default.
• W2018317503 doi "https://doi.org/10.1186/1471-2474-13-217" @default.
• W2018317503 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3531309" @default.
• W2018317503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23127247" @default.
• W2018317503 hasPublicationYear "2012" @default.
• W2018317503 type Work @default.
• W2018317503 sameAs 2018317503 @default.
• W2018317503 citedByCount "13" @default.
• W2018317503 countsByYear W20183175032014 @default.
• W2018317503 countsByYear W20183175032015 @default.
• W2018317503 countsByYear W20183175032016 @default.
• W2018317503 countsByYear W20183175032017 @default.
• W2018317503 countsByYear W20183175032018 @default.
• W2018317503 countsByYear W20183175032019 @default.
• W2018317503 countsByYear W20183175032020 @default.
• W2018317503 countsByYear W20183175032021 @default.
• W2018317503 countsByYear W20183175032023 @default.
• W2018317503 crossrefType "journal-article" @default.
• W2018317503 hasAuthorship W2018317503A5016158898 @default.
• W2018317503 hasAuthorship W2018317503A5041369083 @default.
• W2018317503 hasAuthorship W2018317503A5058418181 @default.
• W2018317503 hasAuthorship W2018317503A5079324651 @default.
• W2018317503 hasAuthorship W2018317503A5079822536 @default.
• W2018317503 hasBestOaLocation W20183175031 @default.
• W2018317503 hasConcept C105702510 @default.
• W2018317503 hasConcept C123550912 @default.
• W2018317503 hasConcept C126322002 @default.
• W2018317503 hasConcept C134018914 @default.
• W2018317503 hasConcept C164705383 @default.
• W2018317503 hasConcept C167414201 @default.
• W2018317503 hasConcept C1862650 @default.
• W2018317503 hasConcept C2779959927 @default.
• W2018317503 hasConcept C2781184374 @default.
• W2018317503 hasConcept C43893838 @default.
• W2018317503 hasConcept C71924100 @default.
• W2018317503 hasConcept C99508421 @default.
• W2018317503 hasConceptScore W2018317503C105702510 @default.
• W2018317503 hasConceptScore W2018317503C123550912 @default.
• W2018317503 hasConceptScore W2018317503C126322002 @default.
• W2018317503 hasConceptScore W2018317503C134018914 @default.
• W2018317503 hasConceptScore W2018317503C164705383 @default.
• W2018317503 hasConceptScore W2018317503C167414201 @default.
• W2018317503 hasConceptScore W2018317503C1862650 @default.
• W2018317503 hasConceptScore W2018317503C2779959927 @default.
• W2018317503 hasConceptScore W2018317503C2781184374 @default.
• W2018317503 hasConceptScore W2018317503C43893838 @default.
• W2018317503 hasConceptScore W2018317503C71924100 @default.
• W2018317503 hasConceptScore W2018317503C99508421 @default.
• W2018317503 hasIssue "1" @default.
• W2018317503 hasLocation W20183175031 @default.
• W2018317503 hasLocation W20183175032 @default.
• W2018317503 hasLocation W20183175033 @default.
• W2018317503 hasLocation W20183175034 @default.
• W2018317503 hasOpenAccess W2018317503 @default.
• W2018317503 hasPrimaryLocation W20183175031 @default.
• W2018317503 hasRelatedWork W1779480512 @default.
• W2018317503 hasRelatedWork W1974568996 @default.
• W2018317503 hasRelatedWork W2016840789 @default.
• W2018317503 hasRelatedWork W2081376013 @default.
• W2018317503 hasRelatedWork W2144576666 @default.
• W2018317503 hasRelatedWork W2288942055 @default.
• W2018317503 hasRelatedWork W2309978229 @default.

• next